Isomorphic Labs raising $5B led by Greenoaks and Sequoia as first cancer target nears trials
shiringhaffary · x · 2026-11-18
Per an exclusive by reporter Rebecca Torrence, Isomorphic Labs — the Google DeepMind spinout — is raising a new $5 billion round led by Greenoaks and Sequoia, with Andreessen Horowitz among participants. The company says it's getting closer to clinical trials for its first cancer target.
One of the largest AI-for-Science raises to date, marking a key commercialization moment for AlphaFold-derived drug discovery.
Related event: Isomorphic Labs Raises $5 Billion to Tackle Disease with AI(18 posts)→
More from Venture
- Robotics startup reveals backers: NVIDIA, AMD, Eric Schmidt among investors — zhou_xian_ · 2026-11-18
- Grindr launches AI-powered premium tier priced at $120/month in the US — Polymarket · 2026-11-18
- Perplexity could go public as soon as 2027, CEO Aravind Srinivas says — prasannaalahoti · 2026-11-18
- Ex-Meta founder raises $45M for ComputeDesk to tackle compute risk — arnie_hacker · 2026-11-18
- Anthropic IPO at $78/Share: Six Models Put IRR Anywhere From 8.8% to 57.6% — peterjliu · 2026-11-18
- NerdWallet's organic traffic keeps sliding — another sign AI is eating SEO — gaganghotra_ · 2026-11-18